This is actually a valid question and can only be answered by the Company.
Purely speculating, I believe the reason for the halt in kimberlite testing was for cash preservation. With the granting of the ML, Lucapa can now turn a profit and thus fund the search entirely from proceeds from sales.
I believe this was done to avoid a CR but like I said, only the Company could answer that one.
This is actually a valid question and can only be answered by...
-
- There are more pages in this discussion • 27 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LOM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.004(6.67%) |
Mkt cap ! $16.24M | |||
| Open | High | Low | Value | Volume |
| 6.6¢ | 6.6¢ | 5.5¢ | $47.36K | 820.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 280076 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 116300 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| LOM (ASX) Chart |